Joel Greenblatt's RLAY Position Overview
Joel Greenblatt (via Gotham Asset Management, LLC) currently holds 33,606 shares of Relay Therapeutics, Inc. (RLAY) worth $334,380, representing 0.00% of the portfolio. First purchased in 2021-Q2, this short-term holding has been held for 6 quarters.
Based on 13F filings, Joel Greenblatt has maintained this position in RLAY for several quarters, showing initial confidence in the investment. Largest addition occurred in Q1 2026, adding 33,606 shares. Largest reduction occurred in Q1 2024, reducing 16,135 shares.
Analysis based on 13F filings available since 2013 Q2
Joel Greenblatt's Relay Therapeutics (RLAY) Holding Value Over Time
Track share changes against reported price movement
Quarterly Relay Therapeutics (RLAY) Trades by Joel Greenblatt
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2026 | +33,606 | New Buy | 33,606 | $9.95 |
| Q1 2024 | -16,135 | Sold Out | 0 | $0.00 |
| Q4 2023 | +16,135 | New Buy | 16,135 | $11.01 |
| Q4 2021 | -7,394 | Sold Out | 0 | $0.00 |
| Q3 2021 | -4,028 | Reduce 35.27% | 7,394 | $31.51 |
| Q2 2021 | +11,422 | New Buy | 11,422 | $36.60 |
Joel Greenblatt's Relay Therapeutics Investment FAQs
Joel Greenblatt first purchased Relay Therapeutics, Inc. (RLAY) in Q2 2021, acquiring 11,422 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Joel Greenblatt has held Relay Therapeutics, Inc. (RLAY) for 6 quarters since Q2 2021.
Joel Greenblatt's largest addition to Relay Therapeutics, Inc. (RLAY) was in Q1 2026, adding 33,606 shares worth $334,380.
According to the latest 13F filing for Q1 2026, Joel Greenblatt's firm, Gotham Asset Management, LLC, owns 33,606 shares of Relay Therapeutics, Inc. (RLAY), valued at approximately $334,380.
As of the Q1 2026 filing, Relay Therapeutics, Inc. (RLAY) represents approximately 0.00% of Joel Greenblatt's publicly disclosed stock portfolio, making it one of their key holdings.
Joel Greenblatt's peak holding in Relay Therapeutics, Inc. (RLAY) was 33,606 shares, as reported at the end of Q1 2026.